Evidence map›Paper›PMID 22581917›Full record

ArticleCirculation research2012

Myocardial Isl(+)land: a place with lots of rhythm, but no beat.

Mark A Sussman

Abstract readEditorialComment
In one paragraph

Article in Circulation research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Stem cell populations in the heart and the role of Isl1 positive cells.European journal of histochemistry : EJH · 2013
    Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Mark A Sussman

Funding

Surgery, Physiology and ImmunohistopathologyP01HL085577 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2006 to 2017
$18.4M
Regulation of Signal Transduction to Treat Heart FailureR01HL067245 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2001 to 2021
$6.0M
Stem Cell Signaling in the Pathologically Challenged MyocardiumR37HL091102 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2008 to 2017
$3.8M
Antagonism of myocardial aging and senescence with Pim-1 kinaseR01HL105759 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2011 to 2015
$1.8M
Engineering Cardiac Progenitor Cells to Enhance Myrocardial RegengerationRC1HL100891 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN, WU, JOSEPH C. · 2009 to 2010
$1.0M
Molecular Engineering of Damaged Myocardium To Enhance Regeneration And RepairR01HL113656 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2012 to 2013
$667k
Nucleolar disruption in response to cardiomyopathic stress and injuryR21HL102714 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2010 to 2011
$411k
Inducible Notch improves progenitor cell repair of damaged heartR21HL104544 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2010 to 2011
$411k
Control of Cardiac Growth by Ca2+Dependent Phosphorylation of HistonesR21HL102613 · NHLBI · SAN DIEGO STATE UNIVERSITY · PI SUSSMAN, MARK ALAN · 2010 to 2011
$411k
NHLBI NIH HHS P01 HL085577NHLBI NIH HHS P01HL085577NHLBI NIH HHS R01 HL067245NHLBI NIH HHS R01HL067245NHLBI NIH HHS R01 HL105759NHLBI NIH HHS R01HL105759NHLBI NIH HHS R01 HL113656NHLBI NIH HHS R21 HL102613NHLBI NIH HHS R21HL102613NHLBI NIH HHS R21 HL102714NHLBI NIH HHS R21HL102714NHLBI NIH HHS R21 HL104544NHLBI NIH HHS R21HL104544NHLBI NIH HHS R37 HL091102NHLBI NIH HHS R37HL091102NHLBI NIH HHS RC1 HL100891
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsLIM-Homeodomain ProteinsMyocardial InfarctionMyocardiumSinoatrial NodeTranscription Factorsinsulin gene enhancer binding protein Isl-1LIM-Homeodomain ProteinsTranscription Factors

Identifiers

PMID22581917
PMCPMC3397794

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.